AU652778B2 - Treatment composition - Google Patents

Treatment composition

Info

Publication number
AU652778B2
AU652778B2 AU85742/91A AU8574291A AU652778B2 AU 652778 B2 AU652778 B2 AU 652778B2 AU 85742/91 A AU85742/91 A AU 85742/91A AU 8574291 A AU8574291 A AU 8574291A AU 652778 B2 AU652778 B2 AU 652778B2
Authority
AU
Australia
Prior art keywords
target location
composition
treatment composition
topical application
benefit agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU85742/91A
Other languages
English (en)
Other versions
AU8574291A (en
Inventor
Sheila Elizabeth Francis
Fiona Jane Hutchinson
Malcolm Norcliffe Jones
Ian Gardner Lyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan Nederland Services BV
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909022298A external-priority patent/GB9022298D0/en
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of AU8574291A publication Critical patent/AU8574291A/en
Application granted granted Critical
Publication of AU652778B2 publication Critical patent/AU652778B2/en
Assigned to QUEST INTERNATIONAL B.V. reassignment QUEST INTERNATIONAL B.V. Alteration of Name(s) in Register under S187 Assignors: UNILEVER PLC
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Glass Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU85742/91A 1990-10-15 1991-10-11 Treatment composition Ceased AU652778B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9022298 1990-10-15
GB909022298A GB9022298D0 (en) 1990-10-15 1990-10-15 Treatment composition
IN305BO1991 IN173187B (OSRAM) 1990-10-15 1991-10-14

Publications (2)

Publication Number Publication Date
AU8574291A AU8574291A (en) 1992-04-16
AU652778B2 true AU652778B2 (en) 1994-09-08

Family

ID=26297800

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85742/91A Ceased AU652778B2 (en) 1990-10-15 1991-10-11 Treatment composition

Country Status (6)

Country Link
EP (1) EP0481701B1 (OSRAM)
JP (1) JPH04273815A (OSRAM)
AT (1) ATE128622T1 (OSRAM)
AU (1) AU652778B2 (OSRAM)
IN (1) IN173187B (OSRAM)
ZA (1) ZA918211B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
WO1992014447A1 (en) * 1991-02-14 1992-09-03 Baxter International Inc. Binding of recognizing substances to liposomes
CA2079450A1 (en) * 1991-02-14 1992-08-15 Rimona Margalit Interaction between bioadhesive liposomes and target sites
US5603872A (en) * 1991-02-14 1997-02-18 Baxter International Inc. Method of binding recognizing substances to liposomes
FR2676362B3 (fr) * 1991-05-17 1993-08-13 Oreal Procede pour accroitre l'activite d'au moins un actif dans une composition a usage cosmetique et/ou dermopharmaceutique et composition pour la mise en óoeuvre dudit procede.
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition
ZA962939B (en) * 1995-04-12 1997-10-13 Quest Int Oral care compositions.
EP0737470A1 (en) * 1995-04-12 1996-10-16 Quest International B.V. Oral care compositions
KR19980075132A (ko) * 1997-03-28 1998-11-05 민병무 중간사슬지방산(medium-chain fatty acids)을 유효성분으로 하는 치아우식증 및 치주질환 치료제용 의약조성물
DE19745950A1 (de) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
IN190017B (OSRAM) * 1999-01-25 2003-05-31 Panacea Biotech Ltd
EP1212100B1 (en) * 1999-09-16 2005-04-06 Unilever Plc Delivery system for antidandruff agent
US6861077B1 (en) 2000-03-17 2005-03-01 L'oreal S.A. Use of plant extracts in a cosmetic composition to protect keratinous fibers
US6416745B1 (en) * 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
JP2015083562A (ja) * 2013-09-18 2015-04-30 第一三共ヘルスケア株式会社 特定の平均粒径を有する薬物担体を含有する口腔用組成物
JP6471407B2 (ja) * 2013-12-25 2019-02-20 サンスター株式会社 口腔又は咽喉用組成物
JP6440954B2 (ja) * 2014-03-18 2018-12-19 サンスター株式会社 オーラルケア組成物
FR3071729B1 (fr) * 2017-10-04 2026-01-16 Cementic Ciments dentaires desinfectants comprenant des liposomes
JP6580735B2 (ja) * 2018-03-16 2019-09-25 サンスター株式会社 オーラルケア組成物
WO2021064608A1 (en) * 2019-09-30 2021-04-08 Centitvc - Centro De Nanotecnologia E Materiais Técnicos Funcionais E Inteligentes Capsule for functionalizing a product, method and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911099A (en) * 1974-01-23 1975-10-07 Defoney Brenman Mayes & Baron Long-acting articles for oral delivery and process
US4767615A (en) * 1984-05-03 1988-08-30 Technology Unlimited, Inc. Dental therapy by vesicle delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165238A (en) * 1980-03-12 1984-04-10 Demetrios P. Papahadjopoulos Activated liposomes and method
US4470967A (en) * 1982-10-05 1984-09-11 Iowa State University Research Foundation Lectin-containing anti-viral vaccines for domestic animals and method of preparation
EP0211042A1 (en) * 1985-01-18 1987-02-25 Cooper-Lipotech, Inc. Liposome composition and method
US4762915A (en) * 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles
DK0462145T3 (da) * 1989-03-07 1994-08-08 Genentech Inc Covalente konjugater mellem lipid og oligonucleotid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911099A (en) * 1974-01-23 1975-10-07 Defoney Brenman Mayes & Baron Long-acting articles for oral delivery and process
US4767615A (en) * 1984-05-03 1988-08-30 Technology Unlimited, Inc. Dental therapy by vesicle delivery

Also Published As

Publication number Publication date
AU8574291A (en) 1992-04-16
EP0481701A1 (en) 1992-04-22
IN173187B (OSRAM) 1994-02-26
EP0481701B1 (en) 1995-10-04
ATE128622T1 (de) 1995-10-15
JPH04273815A (ja) 1992-09-30
ZA918211B (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU8574291A (en) Treatment composition
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
MY102741A (en) Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
CA2043033A1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
AU2292088A (en) Cathartics
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
IE791540L (en) Spiro-furanohydantoin derivatives
CA2145302A1 (en) Peptide proteinaceous drug nasal powder composition
RU95112519A (ru) (3,4-ди-фторфенокси)метил оксиран и способ его получения
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
MY104162A (en) A hydrazone compound and production therefor, and an insecticidal composition containing the same.
CA2028287A1 (en) Benzocycloalkylaminopyridinamines and related compounds, a process and intermediates for their preparation and their use as medicaments
DE69132578D1 (de) Cephemderivate
GB2163051B (en) Drug composition for the treating or preventing acne by topical application
NO305655B1 (no) Antiarytmiske og kardiobeskyttende substituerte indenoylguanidiner, deres anvendelse for fremstilling av legemidler, samt legemiddel inneholdende disse
AU2853889A (en) Therapeutic agents for the treatment of peptic ulcer disease
CA2053346A1 (en) Microcapsule compositions for torical treatment
KR910009271A (ko) 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
ES2170377T3 (es) Composicion que contiene quitosana.
MX9706283A (es) Nuevos antibioticos de polieno, 3874 hi a h6, procedimientos para su preparacion y empleo.
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
AU1042888A (en) Pain-killer

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired